Mining And Ores Tenders

Completion of Non-exclusive Am Discount Agreements According to Section 130a (8) Sgb V by Means of a So-called Oh Model to the Active Ingredient Interferon Beta-1a for Subcutaneous Injection (atc Code According to Who: L03ab07)

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V (Open House Model)

Various Open House Contracts 2023

Conclusion of Non-Exclusive Discount Agreements According to § 130A Paragraph 8 Sgb V for the Active Ingredient Iron Carboxymaltose Iil

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Conclusion of a Non-Exclusive Framework Agreement for Control Tests and Preliminary Investigations in the Open House Procedure of the Southwest Branch, Published in 2023

Completion of a Non-exclusive Framework Contract Control Exams and Preliminary Examinations in the Open House Process of the Southwest Branch, Published in 2023

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the Active Ingredient Fingolimod (0.5 Mg)

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Open House Original Discount Contracts 2023-03